DrugUse-v3.4.1(2023EN) - Bewerkingsoverzicht

Update bot op 31 okt 2023 om 18:59

2023-10-31T18:59:53Z

← Oudere versie		Versie van 31 okt 2023 20:59
Regel 26:		Regel 26:
	\|style="width:250px; "\|DCM::ContactInformation.Telecom\|\|*		\|style="width:250px; "\|DCM::ContactInformation.Telecom\|\|*
	\|-		\|-
	\|style="width:250px; "\|DCM::ContentAuthorList\|\|Projectgroep Generieke Overdrachtsgegevens &~~amp;~~ Kerngroep Registratie aan de Bron		\|style="width:250px; "\|DCM::ContentAuthorList\|\|Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
	\|-		\|-
	\|style="width:250px; "\|DCM::CreationDate\|\|5-7-2012		\|style="width:250px; "\|DCM::CreationDate\|\|5-7-2012
Regel 54:		Regel 54:
	\|style="width:250px; "\|DCM::PublicationStatus\|\|Prepublished		\|style="width:250px; "\|DCM::PublicationStatus\|\|Prepublished
	\|-		\|-
	\|style="width:250px; "\|DCM::ReviewerList\|\|Projectgroep Generieke Overdrachtsgegevens &~~amp;~~ Kerngroep Registratie aan de Bron		\|style="width:250px; "\|DCM::ReviewerList\|\|Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
	\|-		\|-
	\|style="width:250px; "\|DCM::RevisionDate\|\|08-09-2023		\|style="width:250px; "\|DCM::RevisionDate\|\|08-09-2023
Regel 101:		Regel 101:
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-312 \| ZIB-312 ]]		\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-312 \| ZIB-312 ]]
	\|aanpassing paragraaf ~~'~~Concept~~'~~		\|aanpassing paragraaf 'Concept'
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-313 \| ZIB-313 ]]		\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-313 \| ZIB-313 ]]
	\|Aanpassen paragraaf ~~'~~Purpose~~'~~		\|Aanpassen paragraaf 'Purpose'
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-316 \| ZIB-316 ]]		\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-316 \| ZIB-316 ]]
	\|Paragraaf ~~'~~Evidence base~~'~~ wijzigen		\|Paragraaf 'Evidence base' wijzigen
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-319 \| ZIB-319 ]]		\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-319 \| ZIB-319 ]]
Regel 117:		Regel 117:
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-94 \| ZIB-94 ]]		\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-94 \| ZIB-94 ]]
	\|Aanpassen tekst van Disclaimer, Terms of Use &~~amp;~~ Copyrights		\|Aanpassen tekst van Disclaimer, Terms of Use & Copyrights
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-154 \| ZIB-154 ]]		\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-154 \| ZIB-154 ]]
Regel 142:		Regel 142:
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-388 \| ZIB-388 ]]		\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-388 \| ZIB-388 ]]
	\|De ToedieningswegCodelijst heeft geen ~~"~~OID: ~~"~~ aanduiding in de onderliggende codelijst.		\|De ToedieningswegCodelijst heeft geen "OID: " aanduiding in de onderliggende codelijst.
	\|}		\|}

Regel 156:		Regel 156:
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-453 \| ZIB-453 ]]		\|style="width:75px; "\|[[ZIBIssues500_0#ZIB-453 \| ZIB-453 ]]
	\|Wijziging naamgeving ZIB~~'~~s en logo~~'~~s door andere opzet van beheer		\|Wijziging naamgeving ZIB's en logo's door andere opzet van beheer
	\|}		\|}

Regel 505:		Regel 505:
	\|Description<!--vsDescription-->		\|Description<!--vsDescription-->
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "~~Heroïne~~ (substance)">Diamorphine</span>		\|<span title = "Heroïne (substance)">Diamorphine</span>
	\|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002]		\|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002]
	\|SNOMED CT		\|SNOMED CT
	\|2.16.840.1.113883.6.96		\|2.16.840.1.113883.6.96
	\|~~Heroïne~~		\|Heroïne
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "Benzodiazepine (substance)">Benzodiazepine</span>		\|<span title = "Benzodiazepine (substance)">Benzodiazepine</span>
Regel 529:		Regel 529:
	\|GHB		\|GHB
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "~~Cocaïne~~ (substance)">Cocaine</span>		\|<span title = "Cocaïne (substance)">Cocaine</span>
	\|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005]		\|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005]
	\|SNOMED CT		\|SNOMED CT
	\|2.16.840.1.113883.6.96		\|2.16.840.1.113883.6.96
	\|~~Cocaïne~~		\|Cocaïne
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "Crack (substance)">Cocaine freebase</span>		\|<span title = "Crack (substance)">Cocaine freebase</span>
Regel 563:		Regel 563:
	\|SNOMED CT		\|SNOMED CT
	\|2.16.840.1.113883.6.96		\|2.16.840.1.113883.6.96
	\|Paddo~~'~~s		\|Paddo's
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "LSD (substance)">Lysergic acid diethylamide</span>		\|<span title = "LSD (substance)">Lysergic acid diethylamide</span>
Regel 589:		Regel 589:
	\|Crystal meth, methamfetamine		\|Crystal meth, methamfetamine
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "Anabool ~~steroïd~~ (substance)">Anabolic androgenic steroid</span>		\|<span title = "Anabool steroïd (substance)">Anabolic androgenic steroid</span>
	\|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007]		\|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007]
	\|SNOMED CT		\|SNOMED CT
	\|2.16.840.1.113883.6.96		\|2.16.840.1.113883.6.96
	\|Anabole ~~steroïde~~		\|Anabole steroïde
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "Laxans (substance)">Laxative</span>		\|<span title = "Laxans (substance)">Laxative</span>
Regel 619:		Regel 619:
	\|Barbituraat		\|Barbituraat
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "~~Opioïdreceptoragonist~~ (substance)">Opioid receptor agonist</span>		\|<span title = "Opioïdreceptoragonist (substance)">Opioid receptor agonist</span>
	\|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=404642006 404642006]		\|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=404642006 404642006]
	\|SNOMED CT		\|SNOMED CT
	\|2.16.840.1.113883.6.96		\|2.16.840.1.113883.6.96
	\|Opiaten zoals morfine, ~~codeïne~~, methadon, oxycodon en andere morfine-derivaten		\|Opiaten zoals morfine, codeïne, methadon, oxycodon en andere morfine-derivaten
	\|-style="vertical-align:top; "		\|-style="vertical-align:top; "
	\|<span title = "4-fluoramfetamine (substance)">4-Fluoroamphetamine</span>		\|<span title = "4-fluoramfetamine (substance)">4-Fluoroamphetamine</span>
Regel 660:		Regel 660:
	:--		:--
	==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==		==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
	To exchange information based on health and care information models, additional, more technical specifications are required.~~<~~BR~~>~~		To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
	Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->		Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
	<ul>		<ul>
	<li>~~HL7®~~ version 3 CDA compatible specifications, available through the Nictiz ART-~~DECOR®~~ environment<!--ftArtDecorReference--> {{ArtDecorLinks\|2023\|7.4}}</li>		<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment<!--ftArtDecorReference--> {{ArtDecorLinks\|2023\|7.4}}</li>
	<li>~~HL7® FHIR®~~ compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks\|2023\|DrugsGebruik}}</li>		<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks\|2023\|DrugsGebruik}}</li>
	</ul>		</ul>
	==Downloads<!--ftDownloadTitle-->==		==Downloads<!--ftDownloadTitle-->==
Regel 676:		Regel 676:
	</ul>		</ul>
	Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png\|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>		Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png\|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
	This page is generated on 26/10/2023 15:50:18 with ZibExtraction v. 9.0.~~8682~~.~~20490~~<!--ftDate--> <BR>		This page is generated on 31/10/2023 18:33:57 with ZibExtraction v. 9.3.8704.31782<!--ftDate--> <BR>
	-----		-----
	<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png\| link= HCIM_Release<!--wikiReleasePage-->_2023(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2023(EN) \|Back to HCIM list<!--hdBackToMainPage--> ]]</div>		<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png\| link= HCIM_Release<!--wikiReleasePage-->_2023(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2023(EN) \|Back to HCIM list<!--hdBackToMainPage--> ]]</div>

Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v3.4.1(2023EN)}} ==General information== Name: '''nl.zorg.DrugUse''' link=DrugsGebruik-v3.4.1(2023NL)
Version: '''3.4.1'''
HCIM Status:Final
Release: '''2023'''
Release s...'

2023-10-26T14:14:54Z

Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v3.4.1(2023EN)}}  ==General information== Name: '''nl.zorg.DrugUse''' link=DrugsGebruik-v3.4.1(2023NL) Version: '''3.4.1''' HCIM Status:Final Release: '''2023''' Release s...'

Nieuwe pagina

{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v3.4.1(2023EN)}}

==General information==
Name: '''nl.zorg.DrugUse''' [[Bestand:NL.png|link=DrugsGebruik-v3.4.1(2023NL)]] 
Version: '''3.4.1''' 
HCIM Status:Final 
Release: '''2023''' 
Release status: Prepublished 
Release date: 15-10-2023

{{ErrataEN|2023|{{PAGENAME}}}}

-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2023(EN)]] [[HCIM_Release_2023(EN) |Back to HCIM list ]]</div>

==Metadata==
{| class="wikitable" style="font-size:90%; width: 750px"
|-
|style="width:250px; "|DCM::CoderList||Kerngroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::ContactInformation.Address||*
|-
|style="width:250px; "|DCM::ContactInformation.Name||*
|-
|style="width:250px; "|DCM::ContactInformation.Telecom||*
|-
|style="width:250px; "|DCM::ContentAuthorList||Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::CreationDate||5-7-2012
|-
|style="width:250px; "|DCM::DeprecatedDate||
|-
|style="width:250px; "|DCM::DescriptionLanguage||nl
|-
|style="width:250px; "|DCM::EndorsingAuthority.Address||
|-
|style="width:250px; "|DCM::EndorsingAuthority.Name||PM
|-
|style="width:250px; "|DCM::EndorsingAuthority.Telecom||
|-
|style="width:250px; "|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.7.4
|-
|style="width:250px; "|DCM::KeywordList||drugsgebruik, verdovende middelen, middelen gebruik, drugs
|-
|style="width:250px; "|DCM::LifecycleStatus||Final
|-
|style="width:250px; "|DCM::ModelerList||Kerngroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::Name||nl.zorg.DrugsGebruik
|-
|style="width:250px; "|DCM::PublicationDate||15-10-2023
|-
|style="width:250px; "|DCM::PublicationStatus||Prepublished
|-
|style="width:250px; "|DCM::ReviewerList||Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::RevisionDate||08-09-2023
|-
|style="width:250px; "|DCM::Supersedes||nl.zorg.DrugsGebruik-v3.4
|-
|style="width:250px; "|DCM::Version||3.4.1
|-
|style="width:250px; "|HCIM::PublicationLanguage||EN
|}

==Revision History==
<div class="mw-collapsible mw-collapsed">
'' Only available in Dutch''

Publicatieversie 1.0 (15-02-2013)

Publicatieversie 1.1 (01-07-2013)

Publicatieversie 1.2 (01-04-2015)
{|
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-138 | ZIB-138 ]]
|Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsGebruikStatusCodelijst n.a.v. review terminologie expert.
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-139 | ZIB-139 ]]
|Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsOfGeneesmiddelSoortCodelijst n.a.v. review terminologie expert.
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-158 | ZIB-158 ]]
|Cardinaliteit SoortMiddel aanpassen in bouwsteen OverdrachtDrugsgebruik
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-161 | ZIB-161 ]]
|Het concept Hoeveelheid van bouwsteen OverdrachtDrugsgebruik.
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-167 | ZIB-167 ]]
|Bevindingen Concept inrichting Intoxicatie Roken/ Alcohol en Drugs in EZIS.NET
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-224 | ZIB-224 ]]
|In de klinische bouwsteen OverdrachtDrugsgebruik, concept SoortMiddel komt tagged value DrugsOfGeneesmiddelSoortCodelijst niet overeen met naam gekoppelde valueset DrugsOfGeneesmiddelSoort.
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-225 | ZIB-225 ]]
|In de klinische bouwsteen OverdrachtDrugsgebruik, concept ToedieningsWeg komt tagged value ToedieningsWegCodelijst niet overeen met naam gekoppelde valueset.
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-308 | ZIB-308 ]]
|Prefix Overdracht weggehaald bij de generieke bouwstenen
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-312 | ZIB-312 ]]
|aanpassing paragraaf 'Concept'
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-313 | ZIB-313 ]]
|Aanpassen paragraaf 'Purpose'
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-316 | ZIB-316 ]]
|Paragraaf 'Evidence base' wijzigen
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-319 | ZIB-319 ]]
|Wijzing paragraaf Constraint
|}

Incl. algemene wijzigingsverzoeken:
{|
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-94 | ZIB-94 ]]
|Aanpassen tekst van Disclaimer, Terms of Use & Copyrights
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-154 | ZIB-154 ]]
|Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen.
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-200 | ZIB-200 ]]
|Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken.
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-201 | ZIB-201 ]]
|Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken.
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-309 | ZIB-309 ]]
|EOI aangepast
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-324 | ZIB-324 ]]
|Codelijsten Name en Description beginnen met een Hoofdletter
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-326 | ZIB-326 ]]
|Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015
|}

Publicatieversie 1.2.1 (22-05-2015)
{|
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-388 | ZIB-388 ]]
|De ToedieningswegCodelijst heeft geen "OID: " aanduiding in de onderliggende codelijst.
|}

Publicatieversie 1.2.2 (16-07-2015)
{|
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-418 | ZIB-418 ]]
|Vervallen SNOMED CT code in DrugsOfGeneesmiddelSoortCodelijst
|}

Publicatieversie 3.0 (01-05-2016)
{|
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-453 | ZIB-453 ]]
|Wijziging naamgeving ZIB's en logo's door andere opzet van beheer
|}

Publicatieversie 3.1 (04-09-2017)
{|
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-475 | ZIB-475 ]]
|Terminologiekoppeling Drugsgebruik
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-488 | ZIB-488 ]]
|niet compleet
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-505 | ZIB-505 ]]
|Geen informatie
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-512 | ZIB-512 ]]
|Hoe houd je verschillende adresgegevens uit elkaar?
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-564 | ZIB-564 ]]
|Aanpassing/harmonisatie Engelse conceptnamen
|}

Publicatieversie 3.2 (31-12-2017)
{|
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-555 | ZIB-555 ]]
|Uitbreiding codelijst van ZIB DrugsGebruik
|}

Publicatieversie 3.3 (01-09-2020)
{|
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-936 | ZIB-936 ]]
|DrugsGebruikStatusCodelijst vertalingen corrigeren
|-
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1181 | ZIB-1181 ]]
|DefinitionCodes zib drugGebruik
|}

Publicatieversie 3.4 (01-12-2021)
{|
|-
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1009 | ZIB-1009 ]]
|Aanvullingen zib druggebruik: waardenlijst middelen
|-
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1302 | ZIB-1302 ]]
|Uitbreiding DrugsOfGeneesmiddelSoortCodelijst van de zib DrugsGebruik
|-
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1575 | ZIB-1575 ]]
|Deprecated termen en waardelijsten uit de prepublicatie halen
|}

Publicatieversie 3.4.1 (15-10-2023)
{|
|-
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1974 | ZIB-1974 ]]
|Suggested typo and textual improvements
|}
</div>

==Concept==
Drugs (or: narcotics, amphetamines, intoxicants, highs, hallucinogenics, illegal substances or dope) is a collective term for drugs and chemical substances with a more or less ‘drugging' (anesthetic, boosting and/or hallucinogenic) effect and which can lead to addiction. Drug [Online] Available at: nl.Wikipedia.org/wiki/drug [Accessed: 11 February 2015]. 
 
This information model describes the information asked of the patient about their drug use. 

==Purpose==
Documenting and sharing registration of the drug use, as described in the concept.

==Evidence Base==
Though this information model can also be used to abuse (the patient’s own) medication, the project group eventually decided to focus on information on drug use, as described in the concept. 
Seeing as there is a large variety of ways to record the amount of drugs used, we decided that this part is to be entered as free text. 

==Information Model==
 
<imagemap> Bestand:DrugUse-v3.4.1Model(2023EN).png | center
rect 526 241 671 311 [[#647]]
rect 703 251 880 301 [[#RouteOfAdministrationCodelist]]
rect 704 151 881 201 [[#DrugUseStatusCodelist]]
rect 358 360 448 430 [[#652]]
rect 342 235 466 305 [[#645]]
rect 706 63 915 113 [[#TypeOfDrugOrMedicationCodelist]]
rect 526 139 671 209 [[#646]]
rect 526 50 671 120 [[#650]]
rect 177 308 271 378 [[#642]]
rect 177 209 271 279 [[#649]]
rect 342 107 466 188 [[#643]]
rect 177 112 271 182 [[#641]]
desc none
</imagemap>
 
{| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
||NL-CM:7.4.1
|colspan ="6" style ="padding-left: 0px"|[[Bestand: arrowdown.png | 10px | link=]]DrugUse
|
|Root concept of the DrugUse information model. This concept contains all data elements of the DrugUse information model.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228366006 228366006] Finding relating to drug misuse behavior
|}
|
|-style="vertical-align:top; background-color: #E8D7BE; "
|style = "text-align:center" |[[Bestand: folder.png| 16px | link=]]
||NL-CM:7.4.5
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowdown.png | 10px | link=]]ObservationOfUse
|0..1
|Container for ObservationOfUse. This container contains all data elements of the ObservationOfUse container.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
||NL-CM:7.4.6
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="4" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]StartDate
|0..1
|The date on which the patient started using.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
||NL-CM:7.4.7
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="4" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]StopDate
|0..1
|The date on which the patient quit using.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:7.4.8
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="4" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Amount
|0..1
|The number of units (pills, joints, shots etc.) per day, week, month, or year; or the frequency of use.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:7.4.9
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Comment
|0..1
|Relevant comments on the drug use.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment [Interpretation] Narrative
|}
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:7.4.2
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]DrugOrMedicationType
|0..1
|Type of drug used by the patient.
|
|
{|
|-
|[[Bestand: List2.png | link=#TypeOfDrugOrMedicationCodelist]]||[[#TypeOfDrugOrMedicationCodelist|TypeOfDrugOrMedicationCodelist]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:7.4.3
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]DrugUseStatus
|1
|Indication stating whether there was any drug use in the past or present.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228366006 228366006] Finding relating to drug misuse behavior
|}
|
{|
|-
|[[Bestand: List2.png | link=#DrugUseStatusCodelist]]||[[#DrugUseStatusCodelist|DrugUseStatusCodelist]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:7.4.4
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]RouteOfAdministration
|0..*
|The way the drugs are used.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=410675002 410675002] Route of administration
|}
|
{|
|-
|[[Bestand: List2.png | link=#RouteOfAdministrationCodelist]]||[[#RouteOfAdministrationCodelist|RouteOfAdministrationCodelist]]
|}
|}
Columns Concept and DefinitionCode: hover over the values for more information 
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]

==Example Instances==
''Only available in Dutch''

{|class="wikitable" width="791px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 10%; "|DrugsOfGeneesmiddel
| style="background-color: #1F497D; width: 17%; "|Drugs Gebruik Status
| style="background-color: #1F497D; width: 14%; "|Start datum
| style="background-color: #1F497D; width: 9%; "|Stop datum
| style="background-color: #1F497D; width: 14%; "|Toedieningsweg
| style="background-color: #1F497D; width: 16%; "|Hoeveelheid
| style="background-color: #1F497D; width: 20%; "|Toelichting
|-style=vertical-align:top;
| style="width: 10%; "|XTC
| style="width: 17%; "|misbruikt drugs
| style="width: 14%; "|1985
| style="width: 9%; "|
| style="width: 14%; "|oraal
| style="width: 16%; "|2x per maand
| style="width: 20%; "|Op feestjes en in uitgaanscircuit. Vroeger wat meer dan tegenwoordig.
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 10%; "|DrugsOfGeneesmiddel
| style="background-color: #1F497D; width: 17%; "|Drugs Gebruik Status
| style="background-color: #1F497D; width: 14%; "|Start datum
| style="background-color: #1F497D; width: 9%; "|Stop datum
| style="background-color: #1F497D; width: 14%; "|Toedieningsweg
| style="background-color: #1F497D; width: 16%; "|Hoeveelheid
| style="background-color: #1F497D; width: 20%; "|Toelichting
|-style=vertical-align:top;
| style="width: 10%; "|Heroïne
| style="width: 17%; "|heeft in het verleden drugs gebruikt
| style="width: 14%; "|1970
| style="width: 9%; "|1985
| style="width: 14%; "|intraveneus
| style="width: 16%; "|3x per week
| style="width: 20%; "|
|}

==Instructions==
The 'DrugOrMedicationTypeCodelist is extensible. If the drug in question is not on the codelist, the list can be extended with a code from the SNOMED CT hierarchy 'Substance; <105590001' or if necessary from the hierarchy 'Pharmaceutical/biologic product; < 373873005'.

== Valuesets ==
=== DrugUseStatusCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2
|Binding: Extensible
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Current drug user
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=417284009 417284009]
|SNOMED CT
|2.16.840.1.113883.6.96
|huidige drugsgebruiker
|-style="vertical-align:top; "
|Does not misuse drugs
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228367002 228367002]
|SNOMED CT
|2.16.840.1.113883.6.96
|gebruikt geen drugs
|-style="vertical-align:top; "
|Has never misused drugs
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228368007 228368007]
|SNOMED CT
|2.16.840.1.113883.6.96
|heeft nooit drugs gebruikt
|-style="vertical-align:top; "
|Misused drugs in past
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=44870007 44870007]
|SNOMED CT
|2.16.840.1.113883.6.96
|heeft in het verleden drugs gebruikt
|-style="vertical-align:top; "
|Other
|OTH
|NullFlavor
|2.16.840.1.113883.5.1008
|anders
|}
=== RouteOfAdministrationCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3
|Binding: Extensible
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|ORAAL
|9
|G-Standaard Toedieningswegen
|2.16.840.1.113883.2.4.4.9
|oraal
|-style="vertical-align:top; "
|NASAAL
|6
|G-Standaard Toedieningswegen
|2.16.840.1.113883.2.4.4.9
|nasaal (snuiven)
|-style="vertical-align:top; "
|INHALATIE
|62
|G-Standaard Toedieningswegen
|2.16.840.1.113883.2.4.4.9
|Inhalatie (roken)
|-style="vertical-align:top; "
|INTRAVENEUS
|5
|G-Standaard Toedieningswegen
|2.16.840.1.113883.2.4.4.9
|Intraveneus (spuiten)
|-style="vertical-align:top; "
|Other
|OTH
|NullFlavor
|2.16.840.1.113883.5.1008
|Anders
|}
=== TypeOfDrugOrMedicationCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1
|Binding: Extensible
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Diamorphine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002]
|SNOMED CT
|2.16.840.1.113883.6.96
|Heroïne
|-style="vertical-align:top; "
|Benzodiazepine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372664007 372664007]
|SNOMED CT
|2.16.840.1.113883.6.96
|Benzodiazepine
|-style="vertical-align:top; "
|Methadone
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387286002 387286002]
|SNOMED CT
|2.16.840.1.113883.6.96
|Methadon
|-style="vertical-align:top; "
|Hydroxybutyric acid
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=62821004 62821004]
|SNOMED CT
|2.16.840.1.113883.6.96
|GHB
|-style="vertical-align:top; "
|Cocaine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005]
|SNOMED CT
|2.16.840.1.113883.6.96
|Cocaïne
|-style="vertical-align:top; "
|Cocaine freebase
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229003004 229003004]
|SNOMED CT
|2.16.840.1.113883.6.96
|Crack, base coke
|-style="vertical-align:top; "
|Methylenedioxymethamphetamine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=288459003 288459003]
|SNOMED CT
|2.16.840.1.113883.6.96
|MDMA
|-style="vertical-align:top; "
|Amphetamine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=703842006 703842006]
|SNOMED CT
|2.16.840.1.113883.6.96
|Amfetamine, speed
|-style="vertical-align:top; "
|Cannabis
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=398705004 398705004]
|SNOMED CT
|2.16.840.1.113883.6.96
|Cannabis, wiet marihuana, hasj
|-style="vertical-align:top; "
|Hallucinogenic mushrooms
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229006007 229006007]
|SNOMED CT
|2.16.840.1.113883.6.96
|Paddo's
|-style="vertical-align:top; "
|Lysergic acid diethylamide
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=15698006 15698006]
|SNOMED CT
|2.16.840.1.113883.6.96
|LSD
|-style="vertical-align:top; "
|Ketamine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373464007 373464007]
|SNOMED CT
|2.16.840.1.113883.6.96
|Ketamine
|-style="vertical-align:top; "
|Phencyclidine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=9721008 9721008]
|SNOMED CT
|2.16.840.1.113883.6.96
|PCP
|-style="vertical-align:top; "
|Methamphetamine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387499002 387499002]
|SNOMED CT
|2.16.840.1.113883.6.96
|Crystal meth, methamfetamine
|-style="vertical-align:top; "
|Anabolic androgenic steroid
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007]
|SNOMED CT
|2.16.840.1.113883.6.96
|Anabole steroïde
|-style="vertical-align:top; "
|Laxative
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372800002 372800002]
|SNOMED CT
|2.16.840.1.113883.6.96
|Laxans
|-style="vertical-align:top; "
|Buprenorphine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387173000 387173000]
|SNOMED CT
|2.16.840.1.113883.6.96
|Buprenorfine
|-style="vertical-align:top; "
|Fentanyl
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373492002 373492002]
|SNOMED CT
|2.16.840.1.113883.6.96
|Fentanyl
|-style="vertical-align:top; "
|Barbiturate
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372798009 372798009]
|SNOMED CT
|2.16.840.1.113883.6.96
|Barbituraat
|-style="vertical-align:top; "
|Opioid receptor agonist
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=404642006 404642006]
|SNOMED CT
|2.16.840.1.113883.6.96
|Opiaten zoals morfine, codeïne, methadon, oxycodon en andere morfine-derivaten
|-style="vertical-align:top; "
|4-Fluoroamphetamine
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=33471000146101 33471000146101]
|SNOMED CT
|2.16.840.1.113883.6.96
|4FA en/of 4-fmp
|-style="vertical-align:top; "
|Oxycodone
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=55452001 55452001]
|SNOMED CT
|2.16.840.1.113883.6.96
|Oxycodon
|-style="vertical-align:top; "
|Nitrous oxide
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111132001 111132001]
|SNOMED CT
|2.16.840.1.113883.6.96
|Lachgas
|-style="vertical-align:top; "
|Other
|OTH
|NullFlavor
|2.16.840.1.113883.5.1008
|Anders
|}

==This information model in other releases==

{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|2|2023}}

==Information model references==
====This information model refers to====
:--
====This information model is used in====
:--
==Technical specifications in HL7v3 CDA and HL7 FHIR==
To exchange information based on health and care information models, additional, more technical specifications are required. 
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
<ul>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment {{ArtDecorLinks|2023|7.4}}</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR {{SimplefierLinks|2023|DrugsGebruik}}</li>
</ul>
==Downloads==
This information model is also available as [[Media:nl.zorg.DrugUse-v3.4.1(2023EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.DrugUse-v3.4.1(2023EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
==About this information==
The information in this wikipage is based on Prerelease 2023-1 
SNOMED CT and LOINC codes are based on:
<ul>
<li>SNOMED Clinical Terms versie: 20230930 [R] (september 2023-editie)</li>
<li>LOINC version 2.76</li>
</ul>
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]] 
This page is generated on 26/10/2023 15:50:18 with ZibExtraction v. 9.0.8682.20490 
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2023(EN)]] [[HCIM_Release_2023(EN) |Back to HCIM list ]]</div>

DrugUse-v3.4.1(2023EN) - Bewerkingsoverzicht

Update bot op 31 okt 2023 om 18:59

Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v3.4.1(2023EN)}} ==General information== Name: '''nl.zorg.DrugUse''' link=DrugsGebruik-v3.4.1(2023NL) Version: '''3.4.1''' HCIM Status:Final Release: '''2023''' Release s...'

Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v3.4.1(2023EN)}} ==General information== Name: '''nl.zorg.DrugUse''' link=DrugsGebruik-v3.4.1(2023NL)
Version: '''3.4.1'''
HCIM Status:Final
Release: '''2023'''
Release s...'